Vialwirebiotech, curated
November 21, 2026, 8:40 AM
October 14, 2026
- 9:25 AM · PharmaVoice9:25 AMA new startup takes aim at a suspected culprit in autoimmune disease — PharmaVoice
- 9:17 AM · STAT News9:17 AMSTAT+: The startup chasing ‘general biological intelligence’ — STAT News
- 9:00 AM · BioWorld9:00 AMInsilico Medicine nominates ISM-9546 as autoimmune candidate — BioWorld
- 9:00 AM · BioWorld9:00 AMCaspian Therapeutics advances KO-7246 for diabetes — BioWorld
- 9:00 AM · BioWorld9:00 AMSFH-4090 shows robust PK profile for potential clinical translation — BioWorld
- 9:00 AM · BioWorld9:00 AMSoufflé Therapeutics to push into clinic with series B financing — BioWorld
- 9:00 AM · BioWorld9:00 AMDSB-1559 outperforms olaparib in BRCA1-deficient TNBC — BioWorld
- 8:55 AM · Drug Discovery World8:55 AMMHRA reveals 2030 Strategy to modernise patient-centred regulation — Drug Discovery World
- 8:50 AM · Drug Discovery World8:50 AMPhase Ib data in advanced Parkinson’s disease released as Phase II trial begins — Drug Discovery World
- 8:17 AM · STAT News
- 7:53 AM · STAT News
- 7:00 AM · TechCrunch7:00 AMScimplify raises $25M to challenge China’s grip on critical materials with AI — TechCrunch
- 5:25 AM · Pharmaceutical Technology5:25 AMCharles River partners with Magellan Stem Cells on cell therapy — Pharmaceutical Technology
- 5:00 AM · Drug Discovery World5:00 AMRoche and Zealand drug shows 9.2% mean body weight reduction — Drug Discovery World
- 3:40 AM · Pharmaceutical Technology3:40 AMPfizer partners with Enodia Therapeutics in $500m drug deal — Pharmaceutical Technology
October 13, 2026
- 7:13 PM · TechCrunch
- 4:45 PM · Nikkei Asia4:45 PMFujifilm struggles to deliver on massive biomedical business bet — Nikkei Asia
- 4:35 PM · BioPharma Dive4:35 PMAnother Paragon spinout goes public through reverse merger — BioPharma Dive
- 12:00 PM · BioWorld12:00 PMBiopharma financings approach $100B as capital raises outpace 2025 — BioWorld
- 12:00 PM · BioWorld12:00 PMBMS pivotal wins validate radiopharma, fibrosis bets — BioWorld
- 12:00 PM · BioWorld12:00 PMSitryx delivers positive data on new MOA for atopic dermatitis — BioWorld
- 12:00 PM · BioWorld12:00 PMUS FDA nod validates Asahi Kasei's $920M Aicuris bet — BioWorld
- 12:00 PM · BioWorld12:00 PMUS FDA clears seven NMEs in August, led by Orzeyful, Zenbexus — BioWorld
- 12:00 PM · BioWorld12:00 PMSyntara builds case for disease modification in Parkinson’s — BioWorld
- 12:00 PM · BioWorld12:00 PMNeurizon eyes registrational path as pivotal ALS readout nears — BioWorld
- 12:00 PM · BioWorld12:00 PMVaccine trial starts as Bundibugyo virus outbreak intensifies in DRC — BioWorld
- 12:00 PM · BioWorld12:00 PMOno extends I&I reach in $100M Biohaven deal for IgG degraders — BioWorld
- 10:34 AM · Pharmaceutical Technology10:34 AMTremfya rescues J&J’s immunology sales to fuel strong Q3 — Pharmaceutical Technology
- 10:31 AM · STAT News10:31 AMSTAT+: FTC demands Martin Shkreli divest his pharma stocks — STAT News
- 9:00 AM · BioWorld9:00 AMGZR-102 achieves glycemic control in preclinical diabetes — BioWorld
- 9:00 AM · BioWorld9:00 AMShanghai Longke Pharmaceutical discovers new 17β-HSD13 inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMChina’s NMPA clears IND for Chipscreen’s CS-43158 for AML — BioWorld
- 9:00 AM · BioWorld9:00 AMSynnocare patents new VAV1 degradation inducers — BioWorld
- 9:00 AM · BioWorld9:00 AMDiosynvax announces award to advance hemorrhagic fever vaccine — BioWorld
- 9:00 AM · BioWorld9:00 AMRona licenses ALK7-targeted RNAi therapy to Roche — BioWorld
- 9:00 AM · BioWorld9:00 AMSaniona’s SAN-2465 enhances hippocampal synaptic plasticity — BioWorld
- 9:00 AM · BioWorld9:00 AMRoche identifies new STAT6 inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMSunshine Lake Pharma describes new RSV antivirals — BioWorld
- 9:00 AM · BioWorld9:00 AMOMTX-305 kills FAP+ cells in vitro and in patient-derived models — BioWorld
- 9:00 AM · BioWorld9:00 AMNav1.7-silencing ASC delivers durable analgesia — BioWorld
- 9:00 AM · BioWorld9:00 AMInnocare’s ICP-B161 gains clinical trial clearance in China — BioWorld
- 9:00 AM · BioWorld9:00 AMImmorta Bio advances Senomune-0257 for diseases of aging — BioWorld
- 8:00 AM · BioWorld8:00 AMRegulatory: Priority reviews for Everest, Nanoscope; nod for Novocure — BioWorld
- 5:27 AM · Pharmaceutical Technology5:27 AMChina’s NMPA clears Foresee’s Camcevi 42 mg for prostate cancer — Pharmaceutical Technology
- 4:30 AM · STAT News
- 4:11 AM · Pharmaceutical Technology4:11 AMSouthern Research secures NIH funding for drug testing hub — Pharmaceutical Technology
- 2:05 AM · Bloomberg — Technology2:05 AMPiramal Pharma On Cutting Exposure To China — Bloomberg — Technology
October 12, 2026
- 8:00 PM · Nature Biotechnology8:00 PMIn vivo engineering of CAR natural killer cells for immunotherapy using ligand-directed lipid nanoparticles — Nature Biotechnology
- 8:00 PM · Nature Biotechnology8:00 PMProteomic aging clocks go to trial — Nature Biotechnology
- 5:26 PM · BioPharma Dive5:26 PMFirst Tracks climbs on ‘impressive’ celiac study data — BioPharma Dive
- 12:00 PM · BioWorld12:00 PMMerck DME trispecific in shade of anti-VEGF, safety issue confirmed — BioWorld
- 12:00 PM · BioWorld12:00 PMBA phase III degree: Mirum serum Livmarli to Expand label again? — BioWorld
- 11:58 AM · BioPharma Dive11:58 AMParkinson’s cell therapy developer files to go public — BioPharma Dive
- 11:35 AM · BioPharma Dive11:35 AMBristol Myers dips on ‘confounding’ lung drug results — BioPharma Dive
- 9:43 AM · PharmaVoice9:43 AMLilly is fighting a black market for its new obesity drug even before it launches — PharmaVoice